Previous Article | Next Article 
Journal of Virology, October 2000, p. 8893-8903, Vol. 74, No. 19
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Promoter-Specific Targeting of Human SWI-SNF
Complex by Epstein-Barr Virus Nuclear Protein 2
Daniel Y.
Wu,1,2
Anton
Krumm,3 and
William H.
Schubach1,2,*
Division of Medical Oncology, Department of
Medicine, Veterans Administration Puget Sound Health Care System,
Seattle Division, Seattle, Washington 98108,1
and Division of Medical Oncology, Department of Medicine,
University of Washington Medical Center,2 and
Division of Radiation Oncology, University of
Washington,3 Seattle, Washington 98195
Received 26 April 2000/Accepted 7 July 2000
The multiprotein human SWI-SNF (hSWI-SNF) complex is a
chromatin-remodeling machine that facilitates transcription by
overcoming chromatin-mediated gene repression. We had previously shown
that hSNF5/INI1, an intrinsic, consistent component of the hSWI/SNF complex, is associated with Epstein-Barr nuclear antigen 2 (EBNA2) and
have proposed that EBNA2 directs this complex to key EBNA2-responsive viral and cellular genes. Using chromatin immunoprecipitation and
quantitative PCR, we show that antibodies directed against components
of the hSWI-SNF complex preferentially precipitate chromatin-associated
DNA that contains a targeted EBNA2-responsive element in the context of
both episomal and cellular chromatin. This enrichment does not occur in
EBNA2-negative cells or when the EBNA2-responsive element is mutated.
The stable association of the hSWI-SNF complex with the
EBNA2-responsive promoter can also be disrupted by deletion of the TATA
element, suggesting that EBNA2 in itself is insufficient to mediate
stable targeting of the hSWI-SNF complex. These results demonstrate
that recruitment of the hSWI-SNF complex to selected promoters can
occur in vivo through its interaction with site-specific activator
proteins and that stable targeting may require the presence of basal
transcription factors.
*
Corresponding author. Mailing address: 111-ONC,
Division of Oncology, Veterans Administration Puget Sound Health Care
System, Seattle Division, 1660 S. Columbian Way, Seattle, WA 98108. Phone: (206) 764-2709. Fax: (206) 764-2598. E-mail:
wschu{at}u.washington.edu.
Journal of Virology, October 2000, p. 8893-8903, Vol. 74, No. 19
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lucchesi, W., Brady, G., Dittrich-Breiholz, O., Kracht, M., Russ, R., Farrell, P. J.
(2008). Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2. J. Virol.
82: 7456-7466
[Abstract]
[Full Text]
-
Boccellato, F., Anastasiadou, E., Rosato, P., Kempkes, B., Frati, L., Faggioni, A., Trivedi, P.
(2007). EBNA2 Interferes with the Germinal Center Phenotype by Downregulating BCL6 and TCL1 in Non-Hodgkin's Lymphoma Cells. J. Virol.
81: 2274-2282
[Abstract]
[Full Text]
-
Zraly, C. B., Middleton, F. A., Dingwall, A. K.
(2006). Hormone-response Genes Are Direct in Vivo Regulatory Targets of Brahma (SWI/SNF) Complex Function. J. Biol. Chem.
281: 35305-35315
[Abstract]
[Full Text]
-
Peng, R., Moses, S. C., Tan, J., Kremmer, E., Ling, P. D.
(2005). The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter. J. Virol.
79: 4492-4505
[Abstract]
[Full Text]
-
Pages, F., Galon, J., Karaschuk, G., Dudziak, D., Camus, M., Lazar, V., Camilleri-Broet, S., Lagorce-Pages, C., Lebel-Binay, S., Laux, G., Fridman, W.-H., Henglein, B.
(2005). Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells. Blood
105: 1632-1639
[Abstract]
[Full Text]
-
Chen, H., Huang, J., Wu, F. Y., Liao, G., Hutt-Fletcher, L., Hayward, S. D.
(2005). Regulation of Expression of the Epstein-Barr Virus BamHI-A Rightward Transcripts. J. Virol.
79: 1724-1733
[Abstract]
[Full Text]
-
Lee, J. M., Lee, K.-H., Farrell, C. J., Ling, P. D., Kempkes, B., Park, J. H., Hayward, S. D.
(2004). EBNA2 Is Required for Protection of Latently Epstein-Barr Virus-Infected B Cells against Specific Apoptotic Stimuli. J. Virol.
78: 12694-12697
[Abstract]
[Full Text]
-
Kwiatkowski, B., Chen, S. Y. J., Schubach, W. H.
(2004). CKII Site in Epstein-Barr Virus Nuclear Protein 2 Controls Binding to hSNF5/Ini1 and Is Important for Growth Transformation. J. Virol.
78: 6067-6072
[Abstract]
[Full Text]
-
Gordadze, A. V., Onunwor, C. W., Peng, R., Poston, D., Kremmer, E., Ling, P. D.
(2004). EBNA2 Amino Acids 3 to 30 Are Required for Induction of LMP-1 and Immortalization Maintenance. J. Virol.
78: 3919-3929
[Abstract]
[Full Text]
-
Farrell, C. J., Lee, J. M., Shin, E.-C., Cebrat, M., Cole, P. A., Hayward, S. D.
(2004). Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Proc. Natl. Acad. Sci. USA
101: 4625-4630
[Abstract]
[Full Text]
-
Rosendorff, A., Illanes, D., David, G., Lin, J., Kieff, E., Johannsen, E.
(2004). EBNA3C Coactivation with EBNA2 Requires a SUMO Homology Domain. J. Virol.
78: 367-377
[Abstract]
[Full Text]
-
Alazard, N., Gruffat, H., Hiriart, E., Sergeant, A., Manet, E.
(2003). Differential Hyperacetylation of Histones H3 and H4 upon Promoter-Specific Recruitment of EBNA2 in Epstein-Barr Virus Chromatin. J. Virol.
77: 8166-8172
[Abstract]
[Full Text]
-
Hwang, S., Lee, D., Gwack, Y., Min, H., Choe, J.
(2003). Kaposi's sarcoma-associated herpesvirus K8 protein interacts with hSNF5. J. Gen. Virol.
84: 665-676
[Abstract]
[Full Text]
-
Lee, J. M., Lee, K.-H., Weidner, M., Osborne, B. A., Hayward, S. D.
(2002). Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis. Proc. Natl. Acad. Sci. USA
99: 11878-11883
[Abstract]
[Full Text]
-
Wu, D. Y., Tkachuck, D. C., Roberson, R. S., Schubach, W. H.
(2002). The Human SNF5/INI1 Protein Facilitates the Function of the Growth Arrest and DNA Damage-inducible Protein (GADD34) and Modulates GADD34-bound Protein Phosphatase-1 Activity. J. Biol. Chem.
277: 27706-27715
[Abstract]
[Full Text]
-
Spender, L. C., Cornish, G. H., Sullivan, A., Farrell, P. J.
(2002). Expression of Transcription Factor AML-2 (RUNX3, CBF{alpha}-3) Is Induced by Epstein-Barr Virus EBNA-2 and Correlates with the B-Cell Activation Phenotype. J. Virol.
76: 4919-4927
[Abstract]
[Full Text]
-
Voss, M. D., Hille, A., Barth, S., Spurk, A., Hennrich, F., Holzer, D., Mueller-Lantzsch, N., Kremmer, E., Grasser, F. A.
(2001). Functional Cooperation of Epstein-Barr Virus Nuclear Antigen 2 and the Survival Motor Neuron Protein in Transactivation of the Viral LMP1 Promoter. J. Virol.
75: 11781-11790
[Abstract]
[Full Text]
-
Spender, L. C., Cornish, G. H., Rowland, B., Kempkes, B., Farrell, P. J.
(2001). Direct and Indirect Regulation of Cytokine and Cell Cycle Proteins by EBNA-2 during Epstein-Barr Virus Infection. J. Virol.
75: 3537-3546
[Abstract]
[Full Text]